...
首页> 外文期刊>Neoplasma: Journal of Experimental and Clinical Oncology >Immunohistochemical and histomorphological analysis of rat mammary tumors after simvastatin treatment.
【24h】

Immunohistochemical and histomorphological analysis of rat mammary tumors after simvastatin treatment.

机译:辛伐他汀治疗后大鼠乳腺肿瘤的免疫组织化学和组织形态学分析。

获取原文
获取原文并翻译 | 示例
           

摘要

The results of experimental studies have indicated the pleiotropic effects of statins in organism, e.g. the influence on cell cycle, apoptosis or angiogenesis. In this study, the effects of simvastatin on selected parameters of apoptosis and proliferation in chemocarcinogen-induced mammary tumorigenesis in female rats were determined. Simvastatin was administered dietary at a?dose of 18 mg/kg and highly effective dose of 180 mg/kg the entire experiment (18 weeks). At autopsy mammary tumors were removed and prepared for immunohistochemical and histomorphological analysis. In treated animals (simvastatin 180 mg/kg), significant decrease by 12% in Bcl-2 protein expression and non-significant decrease by 27% of Ki67 protein expression in tumor cells compared to tumor cells in control animals were observed after semiquantitative evaluation. Morphometrical analysis has shown significant proapototic shift in Bcl-2/Bax ratio in tumor cells. In high grade control carcinoma cells, the expression of Ki67 increased by 37% (non-significantly) in comparison with control low grade carcinomas. A?histomorphological analysis of malignant tumors has revealed a?shift from high grade to low grade carcinomas after simvastatin treatment. The noticeable decrease of mammary tumor frequency and incidence in rats after simvastatin treatment was accompanied with antiapoptotic Blc-2 protein decrease and proapoptotic Bax protein increase in this experiment. Keywords: rat, mammary tumors, simvastatin, Bcl-2, Bax, Ki67.
机译:实验研究的结果表明他汀类药物在生物体中的多效性作用,例如他汀类药物。对细胞周期,细胞凋亡或血管生成的影响。在这项研究中,确定了辛伐他汀对化学致癌物诱导的雌性大鼠乳腺肿瘤发生中某些凋亡和增殖参数的影响。在整个实验(18周)中,辛伐他汀的饮食剂量为18 mg / kg,高效剂量为180 mg / kg。在尸检时,乳腺肿瘤被取出并准备进行免疫组织化学和组织形态学分析。在半定量评估后,与对照动物的肿瘤细胞相比,在治疗的动物(辛伐他汀180 mg / kg)中,与对照动物的肿瘤细胞相比,肿瘤细胞中Bcl-2蛋白表达显着下降12%,Ki67蛋白表达非显着下降27%。形态计量学分析表明,肿瘤细胞中Bcl-2 / Bax比值发生了明显的质子转移。与对照低等级癌细胞相比,在高等级对照癌细胞中,Ki67的表达增加了37%(无显着性)。恶性肿瘤的组织形态学分析显示,辛伐他汀治疗后从高等级癌转移到低等级癌。在辛伐他汀治疗后,大鼠乳腺肿瘤发生率和发病率显着下降,同时该实验中抗凋亡的Blc-2蛋白降低和促凋亡的Bax蛋白升高。关键词:大鼠,乳腺肿瘤,辛伐他汀,Bcl-2,Bax,Ki67。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号